Cargando…
Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS
BACKGROUND: The relationship between proteins in different CNS extracellular compartments is unknown. In this study the levels of selected proteins in three compartments in people with progressive multiple sclerosis (PMS) were compared. METHODS: During an open label, phase 1b study on intraventricul...
Autores principales: | Bergman, Joakim, Svenningsson, Anders, Liv, Per, Bergenheim, Tommy, Burman, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390226/ https://www.ncbi.nlm.nih.gov/pubmed/32727487 http://dx.doi.org/10.1186/s12987-020-00205-4 |
Ejemplares similares
-
Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension
por: Bergman, Joakim, et al.
Publicado: (2020) -
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS
por: Bergman, Joakim, et al.
Publicado: (2016) -
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally
por: Svenningsson, Anders, et al.
Publicado: (2015) -
Cerebrospinal fluid cytokines after autologous haematopoietic stem cell transplantation and intrathecal rituximab treatment for multiple sclerosis
por: Burman, Joachim, et al.
Publicado: (2023) -
Inflammatory activity and vitamin D levels in an MS population treated with rituximab
por: Linden, Johan, et al.
Publicado: (2019)